Veracyte Inc (NASDAQ:VCYT)

50.94
Delayed Data
As of 3:59pm ET
 -0.94 / -1.81%
Today’s Change
13.90
Today|||52-Week Range
53.10
+82.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.0B

Company Description

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Contact Information

Veracyte, Inc.
6000 Shoreline Court
South San Francisco California 94080
P:(650) 243-6300
Investor Relations:
(650) 380-4413

Employees

Shareholders

Mutual fund holders66.05%
Other institutional43.68%
Individual stakeholders21.23%

Top Executives

Bonnie H. AndersonChairman & Chief Executive Officer
Keith KennedyChief Operating & Financial Officer
Giulia C. KennedyChief Scientific & Medical Officer
Richard T. KloosExecutive Medical Director
James H. ErlingerSecretary, Executive VP & General Counsel